NeuroBo Pharmaceuticals, Inc.
NASDAQ:NRBO
2.92 (USD) • At close October 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 22.435 | 33.364 | 16.387 | 10.089 | 13.908 | 18.954 | 18.473 | 24.033 | 3.62 | 0.317 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 22.435 | 33.364 | 16.387 | 10.089 | 13.908 | 18.954 | 18.473 | 24.033 | 3.62 | 0.317 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.077 | 0.168 | 0.197 | 0.048 | 0.042 | 0.017 | 0.025 | 0.713 | 0.023 | 0.013 |
Total Current Assets
| 22.512 | 33.532 | 16.584 | 10.683 | 14.118 | 18.954 | 19.009 | 24.746 | 3.643 | 0.33 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 0.248 | 0.002 | 0.215 | 0.285 | 0.35 | 0.012 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.018 |
Other Non-Current Assets
| 0.021 | 0 | 0 | 0 | 0 | 0.728 | 0.008 | 0.008 | 0.847 | 0 |
Total Non-Current Assets
| 0.269 | 0.002 | 0.215 | 0.285 | 0.35 | 0.74 | 0.008 | 0.008 | 0.857 | 0.018 |
Total Assets
| 22.781 | 33.534 | 16.799 | 10.968 | 14.468 | 19.694 | 19.017 | 24.754 | 4.5 | 0.348 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 0.821 | 0.708 | 0.83 | 2.575 | 0.638 | 2.044 | 4.025 | 2.008 | 0.531 | 0.021 |
Short Term Debt
| 0.067 | 0 | 0.026 | 0.024 | 0.022 | 9.437 | 1.355 | 0 | 6.424 | 0.737 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | -2.482 | 0 | 0 | 1.627 | 0.048 |
Other Current Liabilities
| 5.072 | 11.076 | 1.301 | 1.096 | 1.422 | 0.438 | 1.01 | 2.113 | 0.345 | 0.073 |
Total Current Liabilities
| 5.96 | 11.784 | 2.157 | 3.695 | 2.082 | 9.437 | 6.39 | 4.121 | 8.927 | 0.879 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 0.136 | 0 | 0.045 | 0.07 | 0.094 | 0.141 | 8.683 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0.708 | 0 | 0 | 0 | 86.453 | 0.003 | 0.001 | 7.953 | 0 |
Total Non-Current Liabilities
| 0.136 | 0.708 | 0.045 | 0.07 | 0.094 | 86.594 | 8.686 | 0.001 | 7.953 | 0 |
Total Liabilities
| 6.096 | 11.784 | 2.202 | 3.765 | 2.176 | 96.031 | 15.076 | 4.122 | 16.88 | 0.879 |
Equity: | ||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 14.468 | 16.746 | 0 | 24.754 | 7.953 | 0 |
Common Stock
| 0.005 | 0.025 | 0.027 | 0.02 | 0.016 | 0.022 | 0.018 | 0.017 | 0.012 | 0.009 |
Retained Earnings
| -108.265 | -95.795 | -81.828 | -66.544 | -36.866 | -84.111 | -60.474 | -27.059 | -12.392 | -0.584 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0.004 | 0.014 | 0.012 | 0.002 | 0 | -24.754 | -7.965 | 0 |
Other Total Stockholders Equity
| 124.945 | 117.52 | 96.394 | 73.713 | 34.662 | -8.996 | 64.397 | 47.674 | 0.012 | 0.044 |
Total Shareholders Equity
| 16.685 | 21.75 | 14.597 | 7.203 | 12.292 | -76.337 | 3.941 | 20.632 | -12.38 | -0.531 |
Total Equity
| 16.685 | 21.75 | 14.597 | 7.203 | 12.292 | -76.337 | 3.941 | 20.632 | -12.38 | -0.531 |
Total Liabilities & Shareholders Equity
| 22.781 | 33.534 | 16.799 | 10.968 | 14.468 | 19.694 | 19.017 | 24.754 | 4.5 | 0.348 |